Method of treating prader-willi syndrome
AssigneeFerring B.V.
InventorsPascal Danglas, Michael Reidy, Paul Korner, Sudarkodi Alagarsamy
Life of this patent
Estimating the term…
Abstract
This disclosure relates to a method of treating Prader-Willi Syndrome. The method includes administering to a patient in need thereof an effective amount of a composition containing a selective oxytocin receptor agonist or a pharmaceutically acceptable salt thereof.
Claims23
A method of treating Prader-Willi Syndrome, comprising administering intranasally to a human patient in need thereof an effective amount of a composition comprising carbetocin or a pharmaceutically acceptable salt thereof, wherein the method comprises administering a daily dose of the carbetocin or pharmaceutically acceptable salt thereof of from about 5.76 mg to about 28.8 mg.
Dependencies are inferred from the claim text.